Immunitybio Inc (IBRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.40B
Last updated: Nov 17, 2026 at 4:43 PM ET
Immunitybio Inc (IBRX) Stock Chart
Immunitybio (IBRX) has a latest price of $6.26 on Nov 17, 2026, 49.6% below its 52-week high of $12.43. Its price rose 201.0% over the past 12 months. The month-end price rose 38.4% over the 10 years through Oct 2026, a compound annual rate of 3.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $32.51 in Feb 2021 and its lowest $1.02 in Jun 2019, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IBRX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IBRX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 23.0%, and over 6 months it fell 19.3%. The month-end price rose 164.0% over the 3 years through Oct 2026, a compound annual rate of 38.2%.
| Period | Change |
|---|---|
| 1 month | -25.7% |
| 3 months | -23.0% |
| 6 months | -19.3% |
| 12 months | +201.0% |
| 12 months, with dividends | +201.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +164.0% | +38.2% |
| 5 years | +5.9% | +1.1% |
| 10 years | +38.4% | +3.3% |
Price by Year
Its best calendar year was 2020, when the price rose 251.7%, and its weakest was 2018, when it fell 74.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $8.29 | +318.7% |
| 2025 | $1.98 | -22.7% |
| 2024 | $2.56 | -49.0% |
| 2023 | $5.02 | -1.0% |
| 2022 | $5.07 | -16.6% |
| 2021 | $6.08 | -54.4% |
| 2020 | $13.33 | +251.7% |
| 2019 | $3.79 | +226.7% |
| 2018 | $1.16 | -74.2% |
| 2017 | $4.49 | -21.5% |
Trading Range
The price is 26.4% below its 50-day average of $8.51 and 21.4% below its 200-day average of $7.97.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $6.26 | |
| 52-week high | $12.43 | -49.6% |
| 52-week low | $1.95 | +221.0% |
| 50-day average | $8.51 | -26.4% |
| 200-day average | $7.97 | -21.4% |
Price Risk
Over 3 years, its largest fall from a peak was 79.3%.
| Measure | Value |
|---|---|
| 1-year beta | 1.40 |
| Largest fall, 1 year | -48.2% |
| Largest fall, 3 years | -79.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IBRX
What is IBRX's 1-year price change?
Immunitybio's price rose 201.0% over the past 12 months. With dividends included, the 12-month total return was 201.0%.
What is IBRX's 5-year price change?
Immunitybio's month-end price rose 5.9% over the 5 years through Oct 2026, a compound annual rate of 1.1%. These figures leave out dividends.
What is IBRX's 52-week high and low?
Immunitybio's 52-week high is $12.43 and its 52-week low is $1.95. Its latest price of $6.26 on Nov 17, 2026 is 49.6% below the high.
What is IBRX's beta?
Immunitybio's 1-year beta against the S&P 500 is 1.40, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 48.2%.
Is the IBRX chart free?
Yes. Advanced Charting for IBRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IBRX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors